Company / Total Assets
FATE THERAPEUTICS INC Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$318.9M
FY2025
5-year range
$318.9M / $921.5M
FY2021-FY2025
Trend
-27.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 4 consecutive years, from $921M in FY2021 to $319M in FY2025.
Based on SEC 10-K filings.
$319M in FY2025 with a 5-year CAGR of -12.5%.
Declined from $506M to $319M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -23.3%
- 5-Year CAGR
- -12.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- FATE THERAPEUTICS INC's total assets has declined for 4 consecutive years.
- 5-year CAGR of -12.5%, indicating a declining trend.
- In FY2025, total assets decreased 27.6% year-over-year.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $318.9M | -27.6% |
| FY2024 | $440.7M | -12.9% |
| FY2023 | $506.2M | -28.3% |
| FY2022 | $705.6M | -23.4% |
| FY2021 | $921.5M | +48.0% |
| FY2020 | $622.5M | +105.9% |
| FY2019 | $302.3M | +41.9% |
| FY2018 | $213.0M | +102.3% |
| FY2017 | $105.3M | +10.8% |
| FY2016 | $95.0M | +39.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026